Article Examines Coverage of Biosimilars
A recent article published in JAMA examines how commercial health plans cover biosimilars compared to their reference products. While Congress [...]
Study: No Confirmed Benefit of Hydroxychloroquine or Chloroquine in Treatment of COVID-19
Researchers in a recent study were unable to confirm any benefits of hydroxychloroquine or chloroquine in the treatment of COVID-19. [...]
Report: High Drug Prices Could Threaten Access to Coronavirus Treatments
Pharmaceutical companies' high pricing could threaten access to potential COVID-19 treatments, The Guardian reports. Sofosbuvir, a hepatitis C drug, costs [...]
PRMA’s Lodowski Highlights 2020 Updates to ICER’s Value Assessment Framework
PRMA Consulting's Nicole Lodowski in a recent blog post outlines seven key areas that have been updated in the Institute [...]
ICER Posts Report Outlining Planned Review of Supervised Injection Facilities
The Institute for Clinical and Economic Review (ICER) posted a new document outlining a planned review of supervised injection facilities [...]
Inovalon Launches New Platform to Inform COVID-19 Action
Inovalon announced the launch of a new platform aimed at delivering data-driven insights to inform COVID-19 response plans. The Population [...]
Judge Denies Shkreli’s Request for Release
A judge denied Martin Shkreli's request to be released from prison to help in the fight against COVID-19, pharmaphorum reports. [...]
Article Covers Range of Opinions on Remdesivir Pricing
A recent STAT article offers the opinions of several experts on how much Gilead's COVID-19 treatment, remdesivir, should cost. While [...]
ICER Appoints New Members to Independent Councils
The Institute for Clinical and Economic Review (ICER) announced new appointments to each of its three independence evidence appraisal councils. [...]
Free Webinar to Outline Ways to Boost Health Care Value
The Value Institute for Health and Care is set to host a free webinar outlining ways the health care industry [...]
Article: Health Jobs No Longer Recession Proof
While health care jobs have been generally considered recession-proof, the COVID-19 pandemic is breaking that trend, according to a recent [...]
ICER’s Venable Focuses on Patient Engagement
Yvette Venable, the Institute for Clinical and Economic Review's (ICER) vice president of patient engagement, is working to foster stronger [...]
Collecting Data in the Midst of a Pandemic
Evidera's Mariah Baltezegar in a recent blog post considers how to best collect data during the COVID-19 pandemic. Baltezegar writes [...]
ICER: Remdesivir Cost-effective at $4,460
The Institute for Clinical and Economic Review (ICER) has established a starting point for discussion about the price of Gilead's [...]
How Can New Software Bolster HTA?
Panelists in an on-demand webinar discuss how new software can be utilized to improve health technology assessment. "The limits of [...]
A Major Milestone for HealthEconomics.Com: A Letter from Dr. Peeples to Our Readers
Few health economists have the mission to create a globally recognized website of highly curated resources for health economics and outcomes research. Neither did I. But, as the unattributed English proverb states, "Necessity is the mother of invention".
Aetion, HealthVerity Launch RWE System
Aetion and HealthVerity last month launched a new real-world evidence system aimed at helping the assessment of treatment approaches for [...]
PRMA Offers Tips on Working From Home
PRMA Consulting in a recent blog post offers six key tips for bolstering connectivity and productivity while working from home. [...]
Blog: What do High Drug Prices Buy Us?
A recent Health Affairs blog post looks at what the U.S. is actually getting with such high drug prices. The [...]
Can Medtech Use Social Media to Generate RWE?
GP and digital RWE advisor Simon Rudland and Orbital Research CEO Peter Brady in a recent interview with Med-Tech Innovation [...]
ISPOR Launches COVID-19 News Service
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has launched a new, COVID-19-focused service to supplement its main site. [...]
A Look at Cummings’ Drug Pricing Law
While the Elijah Cummings Lower Drug Costs Now Act would reduce drug prices, The Commonwealth Fund says the impact on [...]
Preparing for a COVID-19 Vaccine
A recent Health Affairs blog post considers the challenges that lie ahead of a potential COVID-19 vaccine. The rollout of [...]
COVID-19 Evidence Accelerator Aims to Facilitate Collaboration
The Reagan-Udall Foundation, in partnership with Friends of Cancer Research, recently launched a new initiative for the FDA aimed at [...]
ICER Taps Campbell as Senior VP for Health Economics
The Institute for Clinical and Economic Review (ICER) on Thursday, April 23, announced the appointment of Jonathan Campbell as the [...]